The RA Armamentarium: Making Sense of Increasing Treatment Options
On-Demand Slide Lecture with Audio/Monograph
Sponsored by North American Center for Continuing Medical Education, LLC
On-Demand Slide Lecture Presenter/Q&A Cohost
Marc D. Cohen, MD
Professor of Medicine
National Jewish Medical and Research Center
Denver, Colorado
On-Demand Slide Lecture Q&A Cohosts:
Joseph A. Markenson, MD
Professor of Clinical Medicine
Weill Medical College of
Cornell University
Hospital for Special Surgery
New York, New York
Eric M. Ruderman, MD
Associate Professor of Medicine
Division of Rheumatology
Northwestern University
Feinberg School of Medicine
Chicago, Illinois
Target Audience
This activity is designed for rheumatologists and other healthcare professionals who manage the treatment of patients with rheumatoid arthritis (RA).
Learning Objectives
After completing this activity, participants should be able to:
- Evaluate the efficacy and safety of current biologic agents in the treatment of RA
- Formulate individualized treatment plans, including strategies for biologic switching following an inadequate response to RA therapy
- Implement management strategies to reduce safety issues associated with biologic agents
- Evaluate the efficacy and safety of emerging biologic therapies
- Discuss the potential role of emerging biologic agents in optimizing RA management
Activity Overview
The on-demand slide lecture with audio is available with html slides and the presentation transcript. The monograph is available in print and PDF format.
To be eligible for documentation of credit, participants must complete one of the educational activities, complete the 10-question online posttest with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
There is no fee associated with this activity.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for these enduring materials.
Release Date: November 20, 2009
Expiration Date: November 30, 2010
Estimated time to complete: 1 hour
For questions regarding this educational activity, please contact Angela Scarnici at 609-371-1137.
Hardware/Software Requirements
All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
CME Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
NACCME designates each educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Independent Clinical Reviewer: Mandana Hashefi, MD, FACR, Medical Faculty Associates, Division of Rheumatology, George Washington University, Washington, DC
Medical writer Deborah Neveleff contributed to the writing and editing of the monograph article.
Planning Committee
The planning committee comprises Marc D. Cohen, MD, Joseph A. Markenson, MD, Eric M. Ruderman, MD, Mandana Hashefi, MD; Deborah Neveleff; and Randy Robbin, Rosemary Hodgson, Emilie McCardell, Greg Paladino, John Savage, and William Kormos, NACCME.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Cohen: Scientific Consultant—Abbott Laboratories, Amgen Inc, Centocor Ortho Biotech Inc, Genentech, UCB Inc, Wyeth Pharmaceuticals
Dr. Markenson: Grant/Research Support—Abbott Laboratories, Amgen Inc, Bristol-Myers Squibb Company, UCB Inc, Wyeth Pharmaceuticals; Scientific Consultant—Abbott Laboratories, Amgen Inc, Bristol-Myers Squibb Company, UCB Inc, Wyeth Pharmaceuticals; Promotional Speakers’ Bureau—Abbott Laboratories, Amgen Inc, Bristol-Myers Squibb Company, UCB Inc, Wyeth Pharmaceuticals
Dr. Ruderman: Grant/Research Support—Abbott Laboratories, Array Biopharma Inc, Biogen-Idec Inc, Targeted Genetics Corporation; Scientific Consultant—Abbott Laboratories, Amgen Inc, Biogen-Idec Inc, Genentech, Wyeth Pharmaceuticals
Dr. Hashefi: Has disclosed no relevant financial relationships with any commercial interests.
Ms. Neveleff, Mr. Robbin, Ms. Hodgson, Ms. McCardell, Mr. Paladino, Mr. Savage, and Mr. Kormos have reported no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentation.
Faculty have disclosed that tocilizumab and abatacept for use in treatment of patients with rheumatoid arthritis will be discussed.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate reporting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.
Grant Support
Supported by educational grants from Genentech, Inc and Biogen Idec Inc, Bristol-Myers Squibb Company, Centocor Ortho Biotech Inc, UCB Inc, and Abbott Laboratories
Supported by an educational donation provided by Amgen and Wyeth Pharmaceuticals
